Market Cap

C21 Investments, Inc. Market Capitalization:

$36.0 Million

USD as of Jan. 1, 2024

business C21 Investments, Inc. Company Profile

C21 Investments, Inc. Main Stock Listing

OTC: CXXIF

Market Capitalization History of C21 Investments, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of C21 Investments, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $36.0 M 38.33%
Jan. 1, 2023 $26.0 M -53.21%
Jan. 1, 2022 $55.6 M -63.27%
Jan. 1, 2021 $151.5 M 146.48%
Jan. 1, 2020 $61.5 M -76.76%
Jan. 1, 2019 $264.5 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +181.22%

$10,000 in June 2023 would now be $28,122 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

C21 Investments, Inc. Categories

Canada languages Healthcare languages Drug Manufacturers—Specialty & Generic
Canada Healthcare Canada Drug Manufacturers—Specialty & Generic

Stocks & Indices

C21 Investments, Inc. has the following listings and related stock indices.


Stock: OTC: CXXIF

Stock: CSE: CXXI

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.